Join to View Full Profile
5323 Harry Hines BlvdStop 9110Dallas, TX 75390
Phone+1 214-648-0567
Fax+1 214-648-8786
Dr. Margulis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vitaly Margulis is an urologist in Dallas, TX and is affiliated with multiple hospitals in the area, including Children's Medical Center Dallas, Veterans Affairs North Texas Health Care System, and University of Texas Southwestern Medical Center. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 16 years. He also speaks multiple languages, including Spanish, French, Russian, and Ukrainian. He specializes in minimally invasive surgery and surgical oncology and is experienced in prostatitis, urologic oncology, minimally invasive urologic surgery, penile cancer, and bladder.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2009
University of Texas Health Science Center at HoustonResidency, Urology, 2006 - 2008
University of Texas Southwestern Medical CenterResidency, Urology, 2001 - 2006- University of Texas Southwestern Medical CenterInternship, Urology, 2001 - 2002
University of Texas Southwestern Medical SchoolClass of 2001
Certifications & Licensure
OR State Medical License 2014 - Present
TX State Medical License 2002 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy Start of enrollment: 2019 Sep 30
- Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer Start of enrollment: 2021 Sep 06
- Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma Start of enrollment: 2021 Nov 29
Publications & Presentations
PubMed
- Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration).Andrew B Katims, Amy L Tin, Melissa Assel, Patrick Hensley, Roger Li
The Journal of Urology. 2025-10-01 - A structured training curriculum for robot-assisted radical nephroureterectomy: a Delphi consensus study.Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Rashid K Sayyid, Zhenjie Wu, Firas Abdollah
BJU International. 2025-09-17 - Molecular Features and Actionable Gene Targets of Testicular Germ Cell Tumors in a Real-World Setting.Rafael Morales-Grimany, Krinio Giannikou, Cesar Delgado, Kshitij Pandit, Fady Baky
International Journal of Molecular Sciences. 2025-09-15
Authored Content
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Press Mentions
Children’s Research Institute Scientists Uncover Unique Pathway Tumors Use to Acquire Antioxidant LipidsJune 11th, 2025- Amid Surge in Early-Onset Colorectal Cancer, Significant Disparities FoundJune 3rd, 2025
- https://www.oncologynewscentral.com/bladder-cancer/Very-Creative-Approach-to-Bladder-Cancer-Shows-Safety-Efficacy-in-Phase-3-Data?Ap=358June 3rd, 2025
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish, French, Russian, Ukrainian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
